KLSE (MYR): HARTA (5168)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
3.56
Today's Change
+0.02 (0.56%)
Day's Change
3.50 - 3.58
Trading Volume
944,700
14 people like this.
33,956 comment(s). Last comment by findfreedom 1 day ago
2025-01-15
2025-01-15
2025-01-14
2025-01-14
2025-01-13
2025-01-09
2025-01-07
2025-01-07
2025-01-07
2025-01-07
2025-01-07
jolynce
547 posts
Posted by jolynce > 2022-02-12 23:42 | Report Abuse
Observatory, thank you for taking the time to share your knowledge. I split the bet between Harta, Top Glove and Kossan (in that order). Harta makes up the most of my investment in Bursa at 23%. Over invested yes, but it used to be close to 50% before last qtr ex-dividend. That was nerve-wrecking LOL!
Posted by observatory > Feb 12, 2022 8:13 PM | Report Abuse
@tonypang01, Top Glove pre-pandemic earnings was above RM400m per year. The company has since expanded its capacity by nearly half. Let's assume upon normalization, sales can keep up and margin remains like pre-Covid. So earning increases proportionally, say reaching RM700m. With current market cap is RM17.7b, implied forward PE is 25 times.
But Top Glove has almost zero net cash now (after deducting perpetual sukuk). It may manage to raise cash via HK listing but at the expense of equity dilution. The plus is being the largest producer may confer advantages.
With this naïve calculation, the forward PE of Harta at 34X > Top Glove 25X > Supermax & Kossan at about 20X.
Net cash consideration: Harta ~15% market cap, Top Glove zero, Kossan 40%, Supermax 100% (but watch out whether Supermax may squander its cash in US, not to mention we have no idea when sanctions will be lifted)
Based on the relative track records of these firms, the market seems to have priced them in the right sequence. I have no idea which one offers a better tradeoff.
Maybe split the bet? Maybe wait until there is more clarity on future normalization path?